About CapNostics
CapNostics is a Healthcare company based in Newtown Square (United States) founded in 2013, and was acquired by Lucid Diagnostics in October 2021. FDA-cleared swallowable device is used for non-endoscopic GI screening. The company was acqui-hired. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Screening Devices. Its competitors include Auris Health, Apollo Endo and Pentax Medical; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2013 and based in Newtown Square, United States, CapNostics operates in the medical device sector. A swallowable device for non-endoscopic specimen collection is provided to funded cancer research institutions, supporting lab tests for early detection of Barretts Esophagus, upper GI cancers, and H. pylori. CE Class I certification is being completed to enable marketing in the European Union.
- Headquarters Newtown Square, United States
- Stage Acquired
- SectorsHealthcare
- Website capnostics.com
- Social LinkedIn
- Acquired by Lucid Diagnostics (Oct 2021)
- Investors
- Acquired byLucid Diagnostics
(Oct 2021)
Investors in CapNostics
CapNostics has secured backing from 1 investor. Prominent investors backing the company include Lucid Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diagnostic kits for esophageal cancer biomarkers are developed. | 2018 | luciddx.com | New York, United States |
Investor details for CapNostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CapNostics
2 dated milestones of CapNostics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded CapNostics is founded.
- Exit Acquired by Lucid Diagnostics.
Competitors of CapNostics
CapNostics has 3 listed competitors in our database, 2 of them funded. They include Auris Health, Apollo Endo and Pentax Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aurishealth.com | 2007 | Redwood, United States | $733.62M | 242 | Robotic microsurgical systems for endoscopy are developed. | |
| apolloendo.com | 2005 | Austin, United States | $80.36M | 132 | Therapeutic devices for obesity and GI disorders are developed. | |
| pentaxmedical.com | 1976 | Montvale, United States | Endoscopic imaging devices and solutions are developed and marketed. |
Detailed competitors of CapNostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Imaging Diagnostics
3 companies that operate in the same segment as CapNostics (Imaging Diagnostics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CapNostics
CapNostics was founded in 2013.
CapNostics is headquartered in Newtown Square, United States. It is registered at Newtown Square, Pennsylvania, United States.
Founded in 2013 and based in Newtown Square, United States, CapNostics operates in the medical device sector. A swallowable device for non-endoscopic specimen collection is provided to funded cancer research institutions, supporting lab tests for early detection of Barretts Esophagus, upper GI cancers, and H. pylori. CE Class I certification is being completed to enable marketing in the European Union.
CapNostics's top competitors include Auris Health, Apollo Endo and Pentax Medical.
CapNostics has 1 investor. Key investors include Lucid Diagnostics.
Yes. CapNostics was acquired by Lucid Diagnostics in October 2021.